Science for a better life

New AMR Action Fund Steps in to Save Collapsing Antibiotic Pipeline

Explore Your Topic

New Podcast: Tune in to See Science and Agriculture through a Whole New Lens

Update on COVID-19

Our Commitment during the Coronavirus Pandemic

Advancing Culture

Inclusion & Diversity at Bayer

Our Products

Can We Live Better?

If you could cure the incurable, would you?

Can We Live Better?

Should intimate health problems be taboo or treatable?

Can We Live Better?

Can we grow more from less?

Can We Live Better?

Can 10 billion of us live better?

Can We Live Better?

Are we becoming allergic to the 21st century?

Major Legacy Monsanto Matters including U.S. Roundup™ Litigation

Bayer Reaches A Series Of Agreements

The Sustainability Council of Bayer

Uses and Safety Record

Let’s Talk About Glyphosate

Your Second Self: 10 Fascinating Insights into the Human Microbiome

Can Food Supply Chains Cope with COVID-19?

The Pollen Problem

How Close Are We to Finding a Treatment for COVID-19?

read more All COVID-19 news

How Farmers Are Keeping Us Fed through the Global Crisis

Quarterly Statement Q1 2020

Good start to 2020 – activities marked by COVID-19

Science at Home with Bayer

Tuesday, April 28, 2020

Annual Stockholders’ Meeting of Bayer AG

Read more Recording

Blog by Werner Baumann

Coronavirus: Back To A Degree Of Normality

Read more All COVID-19 news

Monday, April 27, 2020

Investor Conference Call on the 1^st Quarter

Read more Recording

Understanding Cardiovascular Diseases

Focusing on the Heart of the Action

Transgender At Bayer

Nicole’s Coming Out At Her Workplace

An Active Substance From Bayer Could Help

Blog by Matthias Berninger

Unite behind Science!

Bayer Employees in China

Fighting the Coronavirus as one team

Blog by Cristina Alonso

Our Commitment to Safe Pesticide Solutions

Annual Report 2019

Bayer Strategically and Operationally Successful

LinkedIn Blog by
Matthias Berninger

The Clock Is Running - It's Time to Act

Investor Conference Call: Crop Science R&D Pipeline Update

February 27, 2020

Financial News Conference: Full Year 2019 Results

Read more Recording

Thursday, February 13, 2020

Media Call: Crop Science R&D Pipeline Showcase

New Investment to Address the Global Organ Shortage Crisis

Blog Post by Werner Baumann

Business and Sustainability Must Go Hand-in-Hand

Blog Post by Liam Condon

How to Take Agriculture Forward Together

Deploying Antibodies to Deliver Targeted Radiation Energy

Industrial Processes

Making Chemistry greener

Discovering Hands

Visually Impaired Can Detect Breast Cancer Earlier

Investor Conference Call

Bayer 2030 Sustainable Development Objectives

Bananas At Risk

How to Recognize a Stroke

Portrait Professor Tobias Erb

Boosting CO2 Reduction with Synthetic Biology

New Investment to Address the Global Organ Shortage Crisis

Quarterly Statement Q3 2019

Encouraging Business Performance Across all Divisions

read more Recording

Social Commitment

Menstrual Cups Are Helping Schoolgirls in Africa

Science and Society

What Do We Really Think about Science?

Anniversary (information in Spanish)

Celebrating 120 Years of Bayer in Spain

Quarterly Statement Q3 2019

Encouraging Business Performance Across all Divisions

Follow the Panel Sessions - Recording

Future of Farming Dialogue 2019

Interview with
Prof. Dr. Gunther Hirschfelder

“We Must Not Undemocratize Food Issues”

Interview with Matthias Berninger

Bayer Supports Coalition to Protect Amazon Rainforest

We listened. We learned.

Our Commitments on Transparency, Sustainability and Engagement

Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

Maria Is Determined to Fight Her Bowel Cancer

Half-Year Report 2019

Bayer on track in operational business

For Healthcare Professionals Only:

Our Oncology Development Pipeline

How to Combat the Spread of Neglected Tropical Diseases

New Investment for the Next Generation Immuno-Oncology

Dr. Hartmut Klusik:

"We Take Diversity And Inclusion Very Seriously”

Transparency Initiative

Further Bayer Safety Studies Accessible

Modern Breeding in Organic Farming

Demographic Shift

Bayer Is Committed to Healthy Aging

BLEND Community

Bayer Staff Champion Diversity

The Importance
of Variety

BLEND Community

Vanessa Lived Most of Her Life as a Man

Bayer Corporate Blog

Amelie Can
Rely on Her Assistance Dog

Werner Baumann:

"Europe Needs a Culture of Opportunity"

Bayer Corporate Blog

What Does the IPBES Assessment of Biodiversity Mean for Bayer?

Challenges in Agriculture

Two Farmers,
Two Worlds

Quarterly Statement Q1 2019

Strong Operational Start to the Year

Allergies & Asthma

Are you Allergic to your own Home?

Links

Latest News

Share Price / Index

July 9, 2020

Not intended for U.S. and UK Media

Bayer’s finerenone meets primary endpoint in Phase III FIDELIO-DKD renal outcomes study in patients with chronic kidney disease and type 2 diabetes

July 1, 2020

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer issues new senior bonds with a volume of 6 billion euros

June 24, 2020

Bayer announces agreements to resolve major legacy Monsanto litigation

Advance Your Career

Why Bayer

Working at Bayer

Meet Our Employees

Open Jobs

Explore Our Businesses

We address some of the world's most pressing global challenges and continue to develop new solutions. The population is constantly growing and its age is increasing. That is why it needs better medicines and high-quality food in sufficient quantities. Learn more about it here.

Pharmaceuticals

Read more

Consumer Health

Read more

Crop Science

Read more

Animal Health

Read more

Find Your Product

With our products we contribute to the health of people, animals and plants. Here you find an overview of the major Bayer products.

A

Z

Can We Live Better?

Challenges of a Better Tomorrow

Aging Population, big data, prenatal nutrition, water scarcity, animal-human bond: Bayer engages in a conversation about the future that matters the most to you – your own.

Last updated: July 9, 2020